Dec 01, 2021 / 07:30PM GMT
Matthew Oliver O'Brien - Piper Sandler & Co., Research Division - MD & Senior Research Analyst
All right. Good afternoon, everybody. Thank you for joining us. It's Matt O'Brien from Piper's Medtech team. I'm here with you today. We're really pleased to have, to say the least, the DexCom story here. With us today and the company on with us as well from the company is Jereme Sylvain, EVP and Chief Financial Officer.
If you do have questions, we only have about 25 minutes, but if you can enter them at the bottom of the Zoom in the Q&A box or just send me an e-mail at [email protected]. With that preamble out of the way, let's go ahead and get started.
Questions and Answers:
Matthew Oliver O'Brien - Piper Sandler & Co., Research Division - MD & Senior Research AnalystJereme, again, thanks so much for the time today.
Jereme M. Sylvain - DexCom, Inc. - Executive VP, CFO & CAO
Thanks for having us. And look, we greatly appreciate inviting us here